Open access · OA
via Europe PMC
Towards a personalized perspective on gliomas: an epigenetic-immuno-inflammatory aging framework.
Vershinina O, Turubanova V, Franceschi C, Ivanchenko M.
Frontiers in immunology · 2026
Abstract
High-grade gliomas cannot be fully understood without considering the biology of aging. In this study, we demonstrate that a set of genes previously established as predictors of tumor subtype and patient survival in gliomas can also be independently characterized as biomarkers associated with aging. Moreover, their expression changes during aging parallel with those seen in malignant transformation: genes which upregulation worsen prognosis are also upregulated with age. These findings support the hypothesis that glioma progression and aging share partially overlapping molecular mechanisms. We also demonstrate that while accelerated epigenetic and mitotic senescence(definition) - gauged by mathematical models (biological clocks) that track aging through specific changes in the DNA methylation of a set of CpG sites - appears inherent to various molecular variants of gliomas, its nature and prognostic significance vary depending on the specific subtype and the epigenetic clock(definition) model employed. Moreover, accelerated aging does not represent a universal hallmark of aggressiveness but rather a phenomenon specific to individual glioma subtype. In this paper, we provide a detailed discussion of the role of cellular senescence in glioma pathogenesis, with a particular focus on its key contribution to tumor growth control and therapeutic response. Additionally, we highlight the yet unresolved question of whether age-associated inflammation (inflammaging(definition)) acts as an independent driver of glioma progression or whether the tumor itself accelerates aging, and suggest the potential of profiling patients cellular aging in developing personalized treatment strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fimmu.2026.1898095
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
O, V., V, T., C, F., & M., I. (2026). Towards a personalized perspective on gliomas: an epigenetic-immuno-inflammatory aging framework. <em>Frontiers in immunology</em>. https://doi.org/10.3389/fimmu.2026.1898095
Vancouver
O V, V T, C F, M. I. Towards a personalized perspective on gliomas: an epigenetic-immuno-inflammatory aging framework. Frontiers in immunology. 2026. doi:10.3389/fimmu.2026.1898095.
BibTeX
@article{vershinina2026Toward,
title = {Towards a personalized perspective on gliomas: an epigenetic-immuno-inflammatory aging framework.},
author = {Vershinina O and Turubanova V and Franceschi C and Ivanchenko M.},
journal = {Frontiers in immunology},
year = {2026},
doi = {10.3389/fimmu.2026.1898095},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Tumor Biology 2017
Open access · CC-BY
Epigenetic perturbation driving asleep telomerase reverse transcriptase: Possible therapeutic avenues in carcinoma
The Journal of Cell Biology 2011
Open access · OA
Four faces of cellular senescence
Osteoarthritis and Cartilage 2009
Preprint · OA
Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016
Open access · OA
Cellular senescence and tumor promotion: Is aging the key?
Neuro-Oncology 2018
Open access · OA
Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence
International Journal of Molecular Sciences 2020
Open access · CC-BY